Maharajgunj Medical Campus, Institute of Medicine, Kathmandu, Nepal.
Department of Gynecology and Obstetrics, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
J Nepal Health Res Counc. 2022 Jun 2;20(1):12-20. doi: 10.33314/jnhrc.v20i01.3874.
Gestational diabetes mellitus is a condition of glucose intolerance during pregnancy. The burden of Gestational diabetes mellitus is ever increasing including a lower middle-income country like Nepal.
This meta-analysis was conducted in accordance to the guidance of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement. Databases of "Embase", "Google Scholar", "Scopus", "Web of Science" were searched for observational studies in Nepal from 2000 to July 2021. Random effect model was used to estimate the pooled prevalence subgroup analysis.
This systematic review and meta-analysis analyzed 9 studies with a total of 20865 participants. Pooled prevalence of gestational diabetes mellitus was 2.61% (95% CI: 1.25- 5.37). From subgroup analysis, the prevalence of Gestational diabetes mellitus according to the diagnostic criteria were: International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria 6.56% (95% CI: 4.79-8.92), World Health Organization (WHO) criteria 4.81% (95% CI: 3.79-6.08), Diabetes in Pregnancy Study Group of India (DIPSI) criteria 4.71% (95% CI: 3.06-7.18), Carpenter and Coustan criteria (CC) 1.08% (95% CI: 0.43-2.71); prevalence according to the publication time: before 2015 1.20% (95% CI: 3.64-6.41), in and after 2015 4.84% (95% CI: 0.42-3.39); prevalence according to the place: within Kathmandu valley 2.70% (95% CI: 1.17-6.08), outside Kathmandu valley 2.28% (95% CI: 0.26-17.15).
Our study revealed the increasing prevalence of GDM in Nepal. Further large observational studies at local levels are essential to measure the actual burden, risk factors and potential preventive measures for Gestational diabetes mellitus.
妊娠期糖尿病是一种妊娠期间葡萄糖耐量异常的疾病。包括尼泊尔在内的中低收入国家,妊娠期糖尿病的负担也在不断增加。
本荟萃分析按照系统评价和荟萃分析报告的首选报告项目的指导进行。从 2000 年到 2021 年 7 月,在“Embase”、“谷歌学术”、“Scopus”、“Web of Science”数据库中搜索尼泊尔的观察性研究。采用随机效应模型估计汇总患病率亚组分析。
本系统评价和荟萃分析分析了 9 项共 20865 名参与者的研究。妊娠期糖尿病的总患病率为 2.61%(95%可信区间:1.25-5.37)。亚组分析显示,根据诊断标准,妊娠期糖尿病的患病率为:国际糖尿病与妊娠研究组(IADPSG)标准 6.56%(95%可信区间:4.79-8.92),世界卫生组织(WHO)标准 4.81%(95%可信区间:3.79-6.08),印度妊娠糖尿病研究组(DIPSI)标准 4.71%(95%可信区间:3.06-7.18),卡朋特和库斯坦标准(CC)1.08%(95%可信区间:0.43-2.71);根据发表时间的不同,患病率为:2015 年以前为 1.20%(95%可信区间:3.64-6.41),2015 年及以后为 4.84%(95%可信区间:0.42-3.39);根据地点的不同,患病率为:加德满都山谷内为 2.70%(95%可信区间:1.17-6.08),加德满都山谷外为 2.28%(95%可信区间:0.26-17.15)。
我们的研究显示,尼泊尔妊娠期糖尿病的患病率呈上升趋势。进一步在当地进行大规模的观察性研究,对于衡量妊娠期糖尿病的实际负担、危险因素和潜在预防措施至关重要。